Released Nov 15, 2010, during market hours
10-Q filed Nov 15, 2010, 46 days after period end · 0000931731-10-000163
Q3 2010 · 10-Q
Revenue$5.70M$5.70M no prior Q3 2009 on file+33.4% vs Q2 2010
Net Income$760.16K$760.16K no prior Q3 2009 on file+33.8% vs Q2 2010
EPS Diluted$0.10$0.10 no prior Q3 2009 on file+42.9% vs Q2 2010
Gross Profit$2,104,345—
Operating Income$1,246,609—
Operating Cash Flowderived$1,037,596—
Free Cash Flowderived$1,037,596—
Margins · derived
Gross margin36.9%
Operating margin21.9%
Net margin13.3%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
no prior Q3 2009 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tanke Biosciences Corp · CIK 1452011 · Engraved from SEC EDGAR